Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2002 | 07-2002 | 06-2002 | 04-2002 | 03-2002 | |
Sales | 79 | 5,973 | 134 | 6,015 | 613 |
Cost of Goods | N/A | 4,035 | N/A | 4,070 | N/A |
Gross Profit | 79 | 1,938 | 134 | 1,945 | 613 |
Operating Expenses | 1,961 | 1,783 | 2,097 | 1,894 | 2,121 |
Operating Income | -1,882 | 190 | -1,963 | 121 | -1,508 |
Interest Expense | 0 | 61 | 0 | 63 | 0 |
Other Income | 55 | -62 | -635 | -5 | 64 |
Pre-tax Income | -1,827 | 67 | -2,598 | 53 | -1,444 |
Income Tax | N/A | 2 | N/A | 2 | N/A |
Net Income Continuous | -1,827 | 65 | -2,598 | 51 | -1,444 |
Net Income | $-1,827 | $65 | $-2,598 | $51 | $-1,444 |
EPS Basic Total Ops | -31.73 | 0.02 | -42.31 | 0.01 | -26.44 |
EPS Basic Continuous Ops | -30.11 | 0.02 | -42.82 | 0.01 | -23.81 |
EPS Diluted Total Ops | -31.73 | 0.02 | -42.31 | 0.01 | -26.44 |
EPS Diluted Continuous Ops | -30.11 | 0.02 | -42.82 | 0.01 | -23.81 |
EBITDA(a) | $-1,832 | $349 | $-1,916 | $319 | $-1,455 |